Pandemic Accelerates China’s Drive Into mRNA Treatments
Messenger RNA-based technology that is highly effective in preventing Covid-19 can also be used for treatment of other diseases Key points: High efficacy rates in preventing Covid-19 spark rush by…
Recent Articles
RELATED ARTICLES
- China’s mRNA pioneer Stemirna faces post-Covid reinvention test
-
With healthier finances, Clover Bio shifts to flu and RSV vaccines
2197.HK
- Health Guard plans dual listing to fund HPV vaccine fight
-
Fosun Pharma, CanSino take different paths as Covid lift fade
2196.HK 6185.HK
- CHINA BULLETIN: Manufacturing Contracts, Foreign Investment Plunges
- CHINA BULLETIN: Weak Economic Signals All Around
-
FAST NEWS: CanSino’s revenue plunges as demand dries up for Covid vaccines
6185.HK 688185.SHG
Discover hidden China stock gems in our weekly newsletter